AN AUSTRALIAN Public
Assessment Report (AusPAR)
has been prepared for Actelion’s
Xiaflex (collagenase clostridium
histolyticum) which is approved for
the treatment of adult men with
Peyronie’s disease with a palpable
plaque and penile curvature
deformity of at least 30 degrees at
the start of therapy.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Aug 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Aug 16
OVER a quarter of a million people have sbeen vaccinated against influenza this year through community pharmacies in Queensland, reported the Pharmacy Guild of Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.